While treatment of mice with sublethal doses of TMZ did not significantly affect tumor growth, susceptibility to the drug was significantly improved following PANK4 silencing, as shown by the pronounced reduction in tumor growth (Figure 5E,F, Table S2, Supporting Information). The gene discussed is PANK4; the disease is neoplasm.